Skip to main content
logo
Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
4.810
+0.260 (5.71%)
At close: Aug 7, 2026, 4:00 PM EDT
4.780
-0.030 (-0.62%)
After-hours: Aug 7, 2026, 7:47 PM EDT

Lexeo Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----0.651.66
Revenue Growth
-----60.53%219.59%
Gross Profit
----0.651.66
Operating Income
-97.79-109.26-105.77-68.51-60.51-50.64
Net Income
-87.5-99.96-98.33-66.39-59.28-50.62
Earnings Per Share
-1.45-1.86-3.09-12.40-36.36-32.60
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
193.04181.77121.52121.4777.34135.86
Total Debt
7.377.899.9211.6413.480
Net Cash (Debt)
185.68173.88111.59109.8363.85135.86
Net Cash Growth
105.32%55.82%1.61%72.00%-53.00%362.53%
Net Cash Per Share
2.833.243.5120.5139.1787.50

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-97.99-98.56-81.15-59.5-54.56-44.18
Capital Expenditures
-0.43-0.4-0.48-0.12-0.67-0.19
Free Cash Flow
-98.42-98.96-81.63-59.61-55.23-44.37
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----100.00%100.00%
Operating Margin
-----9252.14%-3055.94%
Pretax Margin
-----9063.76%-3055.04%
Profit Margin
-----9063.76%-3055.04%
FCF Margin
-----8445.26%-2677.73%

Valuation
Selected indicators aren't available for this stock.